Post-Traumatic Stress Disorder (PTSD) is a mental health condition that can develop after exposure to any traumatic event. Symptoms include re-experiencing the trauma (e.g., nightmares, flashbacks), avoidance of trauma related stimuli, cognitive and mood changes and alterations in arousal and reactivity (e.g., irritability, difficulties concentrating).
It is relatively common in the general population with estimates suggesting that 5-10% of the general population may experience PTSD in their lifetime while some groups (e., war veterans) have heightened rates of this condition.
Some anecdotal and observational studies some studies indicate that prescribed cannabis is a promising treatment for PTSD. But the quality of this evidence has been judged low and potentially subject to bias.
So, when it comes to the judging the safety and efficacy of cannabinoids for the treatment of PTSD, there is a need for high quality data.